R1 RCM Inc. (OTCMKTS:ACHI) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(e) On May 16, 2018, the Board of Directors of R1 RCM Inc. (“R1” or the “Company”) approved special, one-time bonuses to certain R1 employees to recognize the extraordinary efforts and significant contributions of these employees in connection with the Intermedix acquisition, which closed on May 8, 2018. The following named executive officers received special, one-time bonuses: Joseph Flanagan, Chief Executive Officer, for $150,000; and Christopher Ricaurte, Chief Financial Officer, for $100,000.
About R1 RCM Inc. (OTCMKTS:ACHI)
R1 RCM Inc., formerly Accretive Health, Inc., is a provider of revenue cycle services to healthcare providers. The Company offers revenue cycle management (RCM) service and physician advisory services (PAS). The Company operates through the business of providing end-to-end management services of revenue cycle operations for the United States-based hospitals and other medical providers segment. It also offers modular services, allowing clients to engage in specific components of its RCM service offering. Its customers are single or multi-hospital healthcare systems, including faith-based healthcare systems, community healthcare systems, academic medical centers and their affiliated ambulatory clinics, and physician practice groups. The Company’s population health solutions (PHS) services are designed to enable healthcare providers to manage the health of a defined patient population by identifying various individuals. The Company utilizes the R1 Performance Stack.
